CHEPLAPHARM Arzneimittel GmbH


This section provides relevant information as well as ongoing and timely updates on the strategic and operative success stories of our steadily growing Company.


Your contact persons

Jens Remmers

Head of Treasury & Investor Relations

IR center of information

Financial Reports

1st December 2022
Earnings Call Q3 2022 Results
29th November 2022
Publication Quarterly Report Q3 2022
1st September 2022
Earnings Call H1 2022 Results
29th August 2022
Publication 1st Half-Year Report 2022
2nd June 2022
Investor Call Quarterly Report Q1 2022
31st May 2022
Publication Quarterly Report Q1 2022
10th May 2022
Investor Call Full Financial Year 2021 audited
29th April 2022
Publication Full Financial Year 2021 audited
30th November 2021
Investor Call Quarterly Report Q3 2021
19th November 2021
Publication Quarterly Report Q3 2021
24th August 2021
Investor Call Quarterly Report Q2 2021
20th August 2021
Publication Quarterly Report Q2 2021
Find out how you can benefit


The latest from CHEPLAPHARM

Minister-President Schwesig visits CHEPLAPHARM

Schwerin/Greifswald (DE), 07/26/2019 – As part of her summer tour through Mecklenburg-Western Pomerania, Minister-President Manuela Schwesig stops by at the CHEPLAPHARM company headquarters in Greifswald; the visit allows her to get a personal impression of the company, which this year was the first company in M-V to win the Axia Best Managed Company Award and is one of the economic lighthouses of the Greifswald region.

The one and a half hour stay included the company presentation and a tour through the shell of the second office building. After spirited discussions with the management and some employees, the Minister-President was impressed by the success story and CHEPLAPHARM’s ambitious future plans: "Mecklenburg-Western Pomerania is developing into a region where health plays a major role. Especially here in Greifswald and the surrounding area, a number of young companies of the biotechnology, medical technology and pharmaceutical sectors have settled and developed well. CHEPLAPHARM can be very proud of its own development. The company is growing and is awarded the highest prizes. This example shows that it is possible to create highly qualified and attractive jobs with promising prospects for the future, especially here in Vorpommern."

CHEPLAPHARM's CEO Sebastian F. Braun highly welcomed Minister-President Schwesig’s visit and thanked her for her interest in the company: "It is a great pleasure and honor for us that you found your way to CHEPLAPHARM during your summer trip through M-V. In particular, we are delighted with your keen interest and your appreciation of our innovative financial and business model. This positive response contributes significantly to our good reputation and credibility in the public arena, without which we would not be able to pursue our plans – to further reinforce our position as a global player in the pharmaceutical industry - that successfully."

Two years ago, German Chancellor Angela Merkel already visited CHEPLAPHARM in the course of touring through her electoral constituency.

Press Office:
CHEPLAPHARM Arzneimittel GmbH | Ziegelhof 24 | 17489 Greifswald | presse(at)

Investor Relations topics

Back to top expand_less